NCT00329810View on ClinicalTrials.gov

Effect on Cognitive Function of a Treatment With Aripiprazole

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Tablets, oral, 15 mg, once daily, 12 weeks.

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00329810 - Effect on Cognitive Function of a Treatment With Aripiprazole | Biotech Hunter | Biotech Hunter